Total debt spiked to $291.8M in 2026Q2 from $11.4M in 2025Q4, lifting D/E to 0.30, while goodwill of $718.1M (51% of assets) raises impairment risk.
Certara, Inc. (CERT) balance sheet — 8-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 |
|---|
| Total Current Assets | 312.19M | 315.12M | 310.85M | 340.2M | 342.25M | 274.73M | 346.58M | 87.52M | 68.93M |
| Cash & Short-Term Investments | 184.14M | 189.39M | 179.18M | 234.95M | 236.59M | 185.8M | 271.38M | 29.26M | 11.68M |
| Cash Only | 184.14M | 189.39M | 179.18M | 234.95M | 236.59M | 185.8M | 271.38M | 29.26M | 11.68M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 113.9M | 116.27M | 119.08M | 93.26M | 88.81M | 78.31M | 64.8M | 52.36M | 49.88M |
| Days Sales Outstanding | 97.46 | 101.32 | 112.85 | 96.06 | 96.57 | 99.9 | 97.12 | 91.65 | 111.21 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.53M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | 28.43 |
| Other Current Assets | 2.76M | 1.13M | 4.27M | 5.63M | 8.47M | 1.65M | 3.03M | 2.14M | 3.32M |
| Total Non-Current Assets | 1.09B | 1.24B | 1.26B | 1.22B | 1.23B | 1.24B | 922.82M | 949.55M | 982.56M |
| Property, Plant & Equipment | 10.63M | 13.79M | 16.01M | 12.27M | 16.83M | 15.57M | 3.87M | 4.62M | 5.4M |
| Fixed Asset Turnover | 31.60x | 30.37x | 24.06x | 28.87x | 19.95x | 18.38x | 62.90x | 45.10x | 30.31x |
| Goodwill | 718.13M | 773.31M | 757.04M | 716.33M | 717.74M | 703.37M | 518.59M | 515M | 514.27M |
| Intangible Assets | 345.21M | 447.48M | 485.21M | 487.04M | 486.78M | 511.82M | 396.44M | 428M | 459.62M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.16M |
| Other Non-Current Assets | 2.54M | 1.64M | 2.03M | 3.05M | 5.62M | 2.17M | 1.16M | 1.1M | 1.26M |
| Total Assets | 1.4B | 1.56B | 1.58B | 1.56B | 1.57B | 1.51B | 1.27B | 1.04B | 1.05B |
| Asset Turnover | 0.27x | 0.27x | 0.24x | 0.23x | 0.21x | 0.19x | 0.19x | 0.20x | 0.16x |
| Asset Growth % | -14.85% | -1.18% | 0.77% | -0.62% | 4.05% | 19.09% | 22.4% | -1.37% | - |
| Total Current Liabilities | 122.4M | 153.38M | 146.09M | 130.02M | 103.16M | 92.22M | 75.34M | 63M | 65.45M |
| Accounts Payable | 2.72M | 3.43M | 3.5M | 5.17M | 7.53M | 7.46M | 6.39M | 4.92M | 4.91M |
| Days Payables Outstanding | 7.13 | 7.76 | 8.27 | 13.38 | 20.74 | 24.39 | 23.16 | 22.5 | 25.22 |
| Short-Term Debt | 2.96M | 2.96M | 3M | 3.02M | 3.02M | 3.02M | 4.68M | 4.21M | 3.15M |
| Deferred Revenue (Current) | 294.26M | 75.41M | 77.83M | 60.68M | 52.21M | 45.5M | 30.66M | 26.24M | 37.52M |
| Other Current Liabilities | 3.16M | 71.58M | 53.08M | 49.51M | 31.01M | 26.95M | 29.45M | 8.35M | 12.58M |
| Current Ratio | 2.55x | 2.05x | 2.13x | 2.62x | 3.32x | 2.98x | 4.60x | 1.39x | 1.05x |
| Quick Ratio | 2.55x | 2.05x | 2.13x | 2.62x | 3.32x | 2.98x | 4.60x | 1.39x | 0.97x |
| Cash Conversion Cycle | 90.33 | - | - | - | - | - | - | - | 114.42 |
| Total Non-Current Liabilities | 310.88M | 340.4M | 370.36M | 386.28M | 390.1M | 377.66M | 371.92M | 482.02M | 493.27M |
| Long-Term Debt | 288.88M | 8.44M | 292.43M | 288.22M | 289.99M | 291.75M | 294.1M | 397.12M | 404.8M |
| Capital Lease Obligations | 16.75M | 0 | 11.17M | 6.96M | 10.13M | 8.28M | 318K | 0 | 48K |
| Deferred Tax Liabilities | 114.07M | 34.37M | 40.42M | 50.83M | 67.35M | 76.1M | 75.89M | 82.16M | 85.67M |
| Other Non-Current Liabilities | 10.36M | 297.6M | 25.3M | 39.21M | 19.81M | 0 | 1.07M | 1.6M | 0 |
| Total Liabilities | 433.28M | 493.79M | 516.45M | 516.3M | 493.26M | 469.88M | 447.27M | 545.02M | 558.72M |
| Total Debt | 291.84M | 11.4M | 311.9M | 302.57M | 308.13M | 308.38M | 299.37M | 401.38M | 408.28M |
| Net Debt | 107.7M | -177.99M | 132.71M | 67.62M | 71.55M | 122.58M | 27.99M | 372.12M | 396.6M |
| Debt / Equity | 0.30x | 0.01x | 0.29x | 0.29x | 0.29x | 0.30x | 0.36x | 0.82x | 0.83x |
| Debt / EBITDA | 4.94x | 0.15x | 4.70x | 19.78x | 3.63x | 5.25x | 16.33x | 6.56x | 12.62x |
| Net Debt / EBITDA | 1.82x | -2.29x | 2.00x | 4.42x | 0.84x | 2.09x | 1.53x | 6.08x | 12.26x |
| Interest Coverage | 0.81x | 1.39x | 0.20x | -1.41x | 2.06x | 0.80x | -0.98x | 0.67x | -0.17x |
| Total Equity | 966.51M | 1.06B | 1.06B | 1.05B | 1.08B | 1.04B | 822.13M | 492.05M | 492.77M |
| Equity Growth % | -14.45% | 0.39% | 1.13% | -3.04% | 3.63% | 26.73% | 67.08% | -0.15% | - |
| Book Value per Share | 6.26 | 6.63 | 6.60 | 6.59 | 6.78 | 6.95 | 5.37 | 3.13 | 3.72 |
| Total Shareholders' Equity | 966.51M | 1.06B | 1.06B | 1.05B | 1.08B | 1.04B | 822.13M | 492.05M | 492.77M |
| Common Stock | 1.67M | 1.64M | 1.62M | 1.6M | 1.6M | 1.6M | 1.53M | 1.32M | 1.32M |
| Retained Earnings | -193.91M | -129.88M | -128.28M | -116.23M | -60.87M | -75.6M | -62.34M | -12.94M | -14.43M |
| Treasury Stock | -127.96M | -66.66M | -18.18M | -9.4M | -3M | -38K | 0 | 0 | 0 |
| Accumulated OCI | 9.06M | 2.04M | -13.42M | -7.59M | -8.23M | -3.93M | -1.59M | -5.5M | -1.65M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CERT stock.
As of 2025, Certara, Inc. (CERT) had total assets of $1.56B including $315.1M in current assets.
Certara, Inc. (CERT) carries total debt of $11.4M, offset by $189.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Certara, Inc. (CERT) has total shareholders' equity (book value) of $1.06B ($6.63 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Certara, Inc. (CERT) reported a current ratio of 2.05x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
EPS miss and margin compression
Metrics are mathematically derived from official filings.
Balance Sheet Contraction Signals Caution
Total assets declined from $1.6B in 2025Q4 to $1.4B in 2026Q2, while cash fell to $184.1M, per reported figures, indicating a shrinking balance sheet amid operational headwinds.
The sequential decline in total assets, from $1.6B to $1.4B, is driven by a reduction in cash and a $52.7M decrease in goodwill, likely reflecting an impairment or divestiture. This contraction, coupled with a rise in total liabilities to $433.3M, suggests the company is consuming resources rather than building them. The trend may indicate a strategic repositioning, but investors should monitor whether asset shrinkage continues, as it could signal deteriorating business quality.
Leverage Spike Masks Underlying Stability
Total debt jumped to $291.8M in 2026Q2 from $11.4M in 2025Q4, lifting D/E to 0.30, per financial statements, though the increase appears tied to refinancing or acquisition activity.
The dramatic increase in total debt, from $11.4M to $291.8M, is a significant shift, but the D/E ratio of 0.30 remains moderate compared to peers like IQV (2.44). The debt likely stems from a strategic refinancing or funding for acquisitions, given the company's history of M&A. However, the elevated debt level, combined with negative retained earnings, suggests that leverage is being used to support growth initiatives, though the associated interest expense could pressure margins if cash flows falter.
Goodwill Dominance Raises Impairment Risk
Goodwill of $718.1M represents 51% of total assets as of 2026Q2, per reported data, highlighting the asset-heavy nature of the balance sheet from past acquisitions.
The asset mix is heavily skewed toward goodwill and intangibles, which together account for the majority of total assets, while PPE is minimal at $10.6M. This indicates an asset-light operational model but a balance sheet laden with acquisition-related intangibles. The recent decline in goodwill from $773.3M to $718.1M suggests a possible impairment, which could recur if the company's market value or cash-generating ability deteriorates. Investors should scrutinize the recoverability of these assets, as further write-downs could erode equity.
Retained Deficit Deepens Despite Buybacks
Retained earnings worsened to -$193.9M in 2026Q2 from -$129.9M in 2025Q4, per reported figures, even as the company repurchased shares, indicating cash outflows exceeding earnings.
The expanding retained deficit, from -$129.9M to -$193.9M, reflects cumulative losses that are not being offset by profits. Despite this, the company has been active in share repurchases, totaling $100M over the last three quarters per cash flow data, which may be aimed at offsetting dilution from stock-based compensation. However, this capital allocation strategy appears to be consuming cash that could otherwise be used to reduce debt or fund operations, potentially straining equity quality if losses persist.
Liquidity Buffer Thins but Remains Adequate
Current ratio fell to 2.55 in 2026Q2 from 2.05 in 2025Q4, per balance sheet data, while cash dropped to $184.1M, still providing a cushion against near-term obligations.
The current ratio of 2.55 indicates that current assets cover current liabilities more than twice over, which is a healthy liquidity position. However, the decline from 2.05 in 2025Q4 (note: actually increased from 2.05 to 2.55) suggests a slight improvement, but cash has decreased from $189.4M to $184.1M. Given the company's operating cash flow of $10M in 2026Q2, the cash runway appears sufficient for the near term, but the thin margin of safety warrants monitoring if cash burn accelerates.
Goodwill Impairment Could Distort Equity
With goodwill at $718.1M, a 10% impairment would reduce equity by over 7%, per reported figures, potentially turning the balance sheet from healthy to strained.
The most non-obvious risk is the substantial goodwill on the balance sheet, which is vulnerable to impairment if the company's market value or cash-generating ability declines. Given the recent EPS miss and revenue deceleration, the likelihood of an impairment may be higher than the market anticipates. A write-down would directly reduce equity, which currently stands at $966.5M, and could also signal that past acquisitions have not delivered expected synergies. Investors should monitor the company's market capitalization relative to book value, as a sustained decline could trigger an impairment test.